Rachelle R. Olsen, Ph.D.

Affiliations: 
2011 Harvard University, Cambridge, MA, United States 
Area:
Cell Biology
Google:
"Rachelle Olsen"

Parents

Sign in to add mentor
Bruce Zetter grad student 2011 Harvard
 (Analysis of Antizyme Inhibitor Function in Prostate Tumor Growth and Centrosome Amplification.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Olsen RR, Ireland AS, Kastner DW, et al. (2021) ASCL1 represses a SOX9 neural crest stem-like state in small cell lung cancer. Genes & Development
Slavish PJ, Chi L, Yun MK, et al. (2020) Bromodomain-selective BET inhibitors are potent antitumor agents against MYC-driven pediatric cancer. Cancer Research
García-López J, Wallace K, Otero JH, et al. (2020) Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma. Cell Reports. 30: 454-464.e5
Wallace K, Garcia-Lopez J, Otero J, et al. (2020) Abstract B30: ARID1A is a haploinsufficient tumor suppressor for N-Myc transformation of neural crest cells Cancer Research. 80
Dammert MA, Brägelmann J, Olsen RR, et al. (2019) MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer. Nature Communications. 10: 3485
Olsen RR, Mary-Sinclair MN, Yin Z, et al. (2015) Antagonizing Bcl-2 family members sensitizes neuroblastoma and Ewing's sarcoma to an inhibitor of glutamine metabolism. Plos One. 10: e0116998
Olsen RR, Chung I, Zetter BR. (2012) Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids. 42: 549-58
Olsen RR, Zetter BR. (2011) Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer. Molecular Cancer Research : McR. 9: 1285-93
Holleman A, Chung I, Olsen RR, et al. (2011) miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene. 30: 4386-98
Olsen RR, Chung I, Zetter BR. (2011) Abstract 248: Control of prostate tumor growth and centriole amplification by antizyme and antizyme inhibitor Cancer Research. 71: 248-248
See more...